Sven Thamm

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Minimally Invasive

Estrogen Receptor

Top Venues

Journal of medicinal chemistry

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Sven Thamm, Marina K Willwacher, Gary E Aspnes, Tom Bretschneider, Nicholas F Brown, Silke Buschbom-Helmke, Thomas Fox, Emanuele M Gargano, Daniel Grabowski, Christoph Hoenke, Damian Matera, Katja Mueck, Stefan Peters, Sophia Reindl, Doris Riether, Matthias Schmid, Christofer S Tautermann, Aaron M Teitelbaum, Cornelius Trünkle, Thomas Veser, Martin Winter, Lars Wortmann
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science. Journal of medicinal chemistry 66 (4) (2023)
Sven Thamm, Marina K Willwacher, Gary E Aspnes, Tom Bretschneider, Nicholas F Brown, Silke Buschbom-Helmke, Thomas Fox, Emanuele M Gargano, Daniel Grabowski, Christoph Hoenke, Damian Matera, Katja Mueck, Stefan Peters, Sophia Reindl, Doris Riether, Matthias Schmid, Christofer S Tautermann, Aaron M Teitelbaum, Cornelius Trünkle, Thomas Veser, Martin Winter, Lars Wortmann
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science. Journal of medicinal chemistry (2023)
Sven Thamm, Marina K Willwacher, Gary E Aspnes, Tom Bretschneider, Nicholas F Brown, Silke Buschbom-Helmke, Thomas Fox, Emanuele M Gargano, Daniel Grabowski, Christoph Hoenke, Damian Matera, Katja Mueck, Stefan Peters, Sophia Reindl, Doris Riether, Matthias Schmid, Christofer S Tautermann, Aaron M Teitelbaum, Cornelius Trünkle, Thomas Veser, Martin Winter, Lars Wortmann
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science. Journal of medicinal chemistry 66 (4) (2023)
Sven Thamm, Marina K Willwacher, Gary E Aspnes, Tom Bretschneider, Nicholas F Brown, Silke Buschbom-Helmke, Thomas Fox, Emanuele M Gargano, Daniel Grabowski, Christoph Hoenke, Damian Matera, Katja Mueck, Stefan Peters, Sophia Reindl, Doris Riether, Matthias Schmid, Christofer S Tautermann, Aaron M Teitelbaum, Cornelius Trünkle, Thomas Veser, Martin Winter, Lars Wortmann
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science. Journal of medicinal chemistry 66 (4) (2023)
Sven Thamm, Marina K Willwacher, Gary E Aspnes, Tom Bretschneider, Nicholas F Brown, Silke Buschbom-Helmke, Thomas Fox, Emanuele M Gargano, Daniel Grabowski, Christoph Hoenke, Damian Matera, Katja Mueck, Stefan Peters, Sophia Reindl, Doris Riether, Matthias Schmid, Christofer S Tautermann, Aaron M Teitelbaum, Cornelius Trünkle, Thomas Veser, Martin Winter, Lars Wortmann
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science. Journal of medicinal chemistry 66 (4) (2023)
Martin Rübbelke, Dennis Fiegen, Margit Bauer, Florian Binder, James Hamilton, Jim King, Sven Thamm, Herbert Nar, Markus Zeeb
Locking mixed-lineage kinase domain-like protein in its auto-inhibited state prevents necroptosis. Proceedings of the National Academy of Sciences of the United States of America 117 (52) (2020)